Mortal Combat for the Painkillers
It's Merck's Vioxx vs. Pharmacia's Celebrex, and they've been about evenly matched. However, Merck may soon gain an edge
By David Shook
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.
You might like:
- These Guys Want to Lend You Money Against Your Bitcoin
- Fed Raises Rates, Eyes Three 2018 Hikes as Yellen Era Nears End
- This Electric Truck Will Probably Beat Tesla’s to Market
- Bitcoin Points Way to ‘Massive Change’ for Commodity Businesses
- Famed Short-Seller Jim Chanos Says Tesla Headed for ‘Brick Wall’